Neoplasia

Displaying 1 - 5 of 5
Manikandan, D. B., Jagadeeshan, S., Mathukkada, S., Shareb, R. A., Prasad, M., Belsamma, L. V. S., Marripati, D., Erez, N., Wainer, M., Geva, A., Raviv, D., Allon, I., Morris, L. G., Su, G. H., Wang, H., Rosenberg, A. J., Kessler, L., Burrows, F., & Elkabets, M. (2025). Anti-PD1 prolongs the response of PI3K and farnesyl transferase inhibition in HRAS- and PIK3CA-mutant head and neck cancers. Neoplasia, 63, 101157. https://doi.org/10.1016/j.neo.2025.101157
Publication Date
Huang, D., Mela, A., Bhanu, N. V., Garcia, B. A., Canoll, P., & Casaccia, P. (2024). PDGF-BB overexpression in p53 null oligodendrocyte progenitors increases H3K27me3 and induces transcriptional changes which favor proliferation. Neoplasia, 57, 101042. https://doi.org/10.1016/j.neo.2024.101042
Publication Date
Cocito, C., Martin, B., Giantini-Larsen, A. M., Valcarce-Aspegren, M., Souweidane, M. M., Szalontay, L., Dahmane, N., & Greenfield, J. P. (2023). Leptomeningeal dissemination in pediatric brain tumors. Neoplasia, 39, 100898. https://doi.org/10.1016/j.neo.2023.100898
Publication Date
Parekh, K., LeBlang, S., Nazarian, J., Mueller, S., Zacharoulis, S., Hynynen, K., & Powlovich, L. (2023). Past, present and future of Focused Ultrasound as an adjunct or complement to DIPG/DMG therapy: A consensus of the 2021 FUSF DIPG meeting. Neoplasia, 37, 100876. https://doi.org/10.1016/j.neo.2023.100876
Publication Date
Cooney, T., Lindsay, H., Leary, S., & Wechsler-Reya, R. (2023). Current studies and future directions for medulloblastoma: A review from the pacific pediatric neuro-oncology consortium (PNOC) disease working group. Neoplasia, 35, 100861. https://doi.org/10.1016/j.neo.2022.100861
Publication Date